Video

Sarcoma Management: Case-Based Discussion

During the Sarcoma Management Case-Based Discussion CME, a multidisciplinary team of Abramson Cancer Center sarcoma experts review a variety of recent sarcoma cases, discuss their coordinated approach to care and considerations from each ...

Video

Primary Hyperparathyroidism: A Multidisciplinary Case Review

Primary hyperparathyroidism affects 1% of the US population and is commonly under recognized and underdiagnosed. In this case based panel conference, experts from across Penn Medicine discuss current recommendations for diagnostic evaluation ...

Video

A Multidisciplinary Approach to the Management of Melanoma & Cutaneous Carcinoma

Penn Medicine and the Abramson Cancer Center’s Tara Miller Melanoma Center present a case-based discussion led by a multidisciplinary team of melanoma and cutaneous oncology experts from medical oncology, surgery, dermatology, and radiation oncology.

Video

Updates on Colorectal Liver Metastases: A Multidisciplinary Approach

This discussion-based CME moderated by Thomas Karasic, MD with short presentations and representation from a multidisciplinary team of specialists on liver-directed interventions from surgical oncology, radiation oncology, and interventional ...

Video

Management and Updates of Medullary Thyroid Cancer

This panel discussion of specialists from across the Penn Medicine health system include endocrinology, pathology and laboratory, medical oncology and surgical oncology discusses Medullary Thyroid Cancer in the context of diagnosis, surgical ...

Podcast

A Peek Inside the Pavilion: Exploring Penn Medicine's Newest Facility

In this interview, Penn Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto provide insider perspectives on the development of the new 1.5 million square foot Pavilion at Penn Medicine, and insight into the successful integration ...

News

Novel Drug Shows Early Promise in Treating Multiple Myeloma

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at ...

News

Penn Medicine Pilots First of Its Kind Blood Test to Measure Immune Response to COVID Vaccine in Immunocompromised Patients

The test measures both antibody and T-cell response to COVID-19 vaccination among multiple sclerosis patients, then integrates results into the electronic health record to aid in clinician and patient decision-making

News

HDR Brachytherapy for Clinically Localized Prostate Cancer

Radiation oncologists at Penn Medicine are now offering high-dose rate brachytherapy for men with clinically localized prostate cancer who are eligible to receive brachytherapy as definitive therapy or in combination with external beam radiation.

Potential Strategy to Improve T Cell Therapy in Solid Tumors

Birth Complications Tied to Death Risk Decades Later

Penn Medicine Suggests More Cancers Can Be Treated with Drugs

Awards & Accolades: February 2023

Three Penn Medicine Faculty Members Named Hastings Center Fellows

Over $5M Awarded to Gun Violence Reduction Programs at Penn